APA (7th ed.) Citation

Park, B. G., Park, Y., Joo, D. J., Huh, K. H., Kim, M. S., Kim, S. I., . . . Kim, H. (2019). Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients. Clinical transplantation and research, 33(3), 47-54. https://doi.org/10.4285/jkstn.2019.33.3.47

Chicago Style (17th ed.) Citation

Park, Borae Geum, Younhee Park, Dong Jin Joo, Kyu Ha Huh, Myoung Soo Kim, Soon Il Kim, Yu Seun Kim, and Hyon-Suk Kim. "Clinical Significance of Donor-specific Anti-HLA-DR51/52/53 Antibodies for Antibody-mediated Rejection in Kidney Transplant Recipients." Clinical Transplantation and Research 33, no. 3 (2019): 47-54. https://doi.org/10.4285/jkstn.2019.33.3.47.

MLA (9th ed.) Citation

Park, Borae Geum, et al. "Clinical Significance of Donor-specific Anti-HLA-DR51/52/53 Antibodies for Antibody-mediated Rejection in Kidney Transplant Recipients." Clinical Transplantation and Research, vol. 33, no. 3, 2019, pp. 47-54, https://doi.org/10.4285/jkstn.2019.33.3.47.